BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Charles G. Mullighan, Christopher B. Miller, Letha A. Phillips, Ina Radtke, James Dalton, Jing Ma, Deborah White, Timothy P. Hughes, Michelle M. Le Beau, Ching-Hon Pui, Mary V. Relling, Sheila A. Shurtleff and James R. Downing [ read more >> ]

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Charles G. Mullighan, Salil Goorha, Ina Radtke, Christopher B. Miller, Elaine Coustan-Smith, James D. Dalton, Kevin Girtman, Susan Mathew, Jing Ma, Stanley B. Pounds, Xiaoping Su, Ching-Hon Pui, Mary V. Relling, William E. Evans, Sheila A. Shurtleff and James R. Downing [ read more >> ]

Gene expression profiling of childhood adrenocortical tumors.
West AN, Neale GA, Pounds S, Figueredo BC, Rodriguez Galindo C, Pianovski MA,
Oliveira Filho AG, Malkin D, Lalli E, Ribeiro R, Zambetti GP. [ read more >> ]

Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocols.
Holleman A, den Boer ML, Cheok MH, Kazemier KM, Pei D, Downing JR, Janka-Schaub GE, Gobel U, Graubner UB, Pui CH, Evans WE, Pieters R. [ read more >> ]